As gov­ern­ment fund­ing dries up, Pfiz­er ex­pects to charge pri­vate pay­ers $110+ for Covid-19 vac­cine

For months, com­pa­nies be­hind Covid-19 vac­cines and ther­a­pies have been talk­ing about tran­si­tion­ing to a pri­vate com­mer­cial mar­ket once the gov­ern­ment fund­ing dries up. As …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER